busulfan has been researched along with Febrile Neutropenia in 2 studies
Febrile Neutropenia: Fever accompanied by a significant reduction in the number of NEUTROPHILS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A bortezomib-containing regimen followed by high-dose therapy and autologous stem cell transplant (ASCT) is considered the standard of care for front-line therapy in younger patients with newly diagnosed multiple myeloma (MM)." | 7.81 | Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma. ( Blanes, M; Boluda, B; de la Rubia, J; González, JD; Lahuerta, JJ; Lorenzo, I; Ribas, P; Sanz, MA, 2015) |
| "A bortezomib-containing regimen followed by high-dose therapy and autologous stem cell transplant (ASCT) is considered the standard of care for front-line therapy in younger patients with newly diagnosed multiple myeloma (MM)." | 3.81 | Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma. ( Blanes, M; Boluda, B; de la Rubia, J; González, JD; Lahuerta, JJ; Lorenzo, I; Ribas, P; Sanz, MA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DY | 1 |
| Chung, JS | 1 |
| Jo, JC | 1 |
| Cho, SH | 1 |
| Shin, HJ | 1 |
| Blanes, M | 1 |
| González, JD | 1 |
| Lahuerta, JJ | 1 |
| Ribas, P | 1 |
| Lorenzo, I | 1 |
| Boluda, B | 1 |
| Sanz, MA | 1 |
| de la Rubia, J | 1 |
1 trial available for busulfan and Febrile Neutropenia
| Article | Year |
|---|---|
Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride | 2020 |
1 other study available for busulfan and Febrile Neutropenia
| Article | Year |
|---|---|
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Busulfan; Combined Modality | 2015 |